Key result
Cardioneuroablation maintains syncope-free status in two young patients with neurally-mediated syncope and functional AV block.
Why the study?
Cardioneuroablation is an emerging alternative therapeutic modality for young patients with severe neurally-mediated syncope.
Does cardioneuroablation prevent syncope in young patients with severe neurally-mediated syncope?
Does cardioneuroablation prevent syncope in young patients with severe neurally-mediated syncope?
Cardioneuroablation appears to be a promising alternative therapeutic modality for preventing syncope in young patients with severe neurally-mediated syncope.
Answers are grounded in this paper and cite their sources.
May be considered for refractory neurally-mediated syncope in young patients; hypothesis-generating and requires prospective trials before broader adoption.
Cardioneuroablation is an emerging alternative therapeutic modality for young patients with severe neurally-mediated syncope. We present two images of cardioneuroablation performed in young patients who suffered from recurrent neurally-mediated syncope with asystole and functional atrioventricular block. The patients remain syncope-free during follow-ups.
No takes yet. Share an insight, caveat, or question.
Letsas et al. (2023) studied this question. Cardioneuroablation maintained a syncope-free status during follow-up in two young patients with recurrent neurally-mediated syncope, asystole, and functional atrioventricular block.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: